Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Vertex Pharmaceuticals (United States) | Researchclopedia

Back to institutions

Vertex Pharmaceuticals (United States)

Bostoncompany

2,661

Works

816,791

Citations

338

h-index

Top Research Topics

Cystic Fibrosis Research Advances Hepatitis C virus research Computational Drug Discovery Methods

Top Researchers

Richard A. Flavell Yale University

1,514 works231,941 citationsh-index: 246

Recent Research

WCN26-5681 DESIGN OF A PHASE 2b/3 ADAPTIVE, RANDOMIZED, ACTIVE-CONTROLLED TRIAL (OLYMPUS) EVALUATING POVETACICEPT IN PRIMARY MEMBRANOUS NEPHROPATHY

Jason Sanders,Ran Duan,et al.

20260 citations

HIV/AIDS drug development and treatment

Statistical Methods in Clinical Trials

Hemoglobinopathies and Related Disorders

Pharmacogenetics and Drug Metabolism

Neonatal Respiratory Health Research

Health Systems, Economic Evaluations, Quality of Life

Protein Structure and Dynamics

Liver Disease Diagnosis and Treatment

Hepatitis B Virus Studies

Steven J.M. Jones University of East Anglia

1,277 works213,410 citationsh-index: 189

David Altshuler Vertex Pharmaceuticals (United States)

428 works211,986 citationsh-index: 157

Vilmundur Guðnason Reykjavík University

1,388 works186,504 citationsh-index: 189

Bradley T. Hyman Harvard University

1,087 works178,967 citationsh-index: 187

D. Brown Brookhaven National Laboratory

995 works153,412 citationsh-index: 136

Validation of Dihydroorotate Dehydrogenase as a Herbicide Target: Discovery of Tetflupyrolimet

Thomas P. Selby,Alison Levens,et al.

20260 citations

Advances in Human Mass Balance Studies: An <scp>IQ</scp> Consortium Perspective on Current Practices and Emerging Trends

Jason Boer,Ellen A. Cannady,et al.

20260 citations

Effect of Elexacaftor/Tezacaftor/Ivacaftor Treatment on Extrapulmonary Complications of Cystic Fibrosis

Jessica Morlando Geiger,Brenna L. Brady,et al.

20260 citations

Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in adolescents and adults with cystic fibrosis and <i>F508del</i> -gating and <i>F508del</i> -residual function genotypes: Results from an open-label extension study

James F. Chmiel,Kimberly McBennett,et al.

20260 citations

Reply: clinical and methodological uncertainty in the economic evaluation of suzetrigine

Kenna Garrison,Alexandra G. Ellis,et al.

20260 citations